Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Portage Biotech Inc Ord (PRTG)

Portage Biotech Inc Ord (PRTG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,454
  • Shares Outstanding, K 17,801
  • Annual Sales, $ 0 K
  • Annual Income, $ -104,610 K
  • 60-Month Beta 0.96
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.17
Trade PRTG with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -6.64
  • Most Recent Earnings $-0.18 on 02/28/24
  • Latest Earnings Date 03/06/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 177.92%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 1,117.31% on 01/19/24
  • IV Low 0.00% on 04/22/24
  • Put/Call Vol Ratio 7.00
  • Today's Volume 8
  • Volume Avg (30-Day) 4
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 1
  • Open Int (30-Day) 2

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.22
  • Number of Estimates 2
  • High Estimate -0.21
  • Low Estimate -0.22
  • Prior Year -5.84
  • Growth Rate Est. (year over year) +96.23%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1999 +18.56%
on 04/17/24
0.6400 -62.97%
on 04/01/24
-0.2460 (-50.93%)
since 03/25/24
3-Month
0.1999 +18.56%
on 04/17/24
1.0500 -77.43%
on 01/29/24
-0.6132 (-72.12%)
since 01/25/24
52-Week
0.1999 +18.56%
on 04/17/24
4.4000 -94.61%
on 06/05/23
-3.0530 (-92.80%)
since 04/25/23

Most Recent Stories

More News
Portage Down on Announcing Alternatives

Portage Biotech Inc. (NASDAQ: PRTG) shares stumbled Friday, as the Westport, Conn.-based company a clinical-stage ...

PRTG : 0.2370 (-5.28%)
New Strong Buy Stocks for January 26th

FYBR, SPPJY, KMTUY, PRTG and ASML have been added to the Zacks Rank #1 (Strong Buy) List on January 26, 2023.

ASML : 902.51 (+1.14%)
KMTUY : 27.3600 (-6.33%)
SPPJY : 2.8000 (-4.92%)
PRTG : 0.2370 (-5.28%)
FYBR : 22.62 (-1.05%)
Best Momentum Stocks to Buy for January 20th

NBSE, PRTG and NOMD made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 20, 2022.

NOMD : 18.64 (-0.90%)
NBSE : 0.4420 (+4.99%)
PRTG : 0.2370 (-5.28%)
New Strong Buy Stocks for January 20th

NBSE, PRTG, RELL, HOWL and PATH have been added to the Zacks Rank #1 (Strong Buy) List on January 20, 2022.

RELL : 9.96 (-1.19%)
PATH : 19.41 (-1.47%)
NBSE : 0.4420 (+4.99%)
PRTG : 0.2370 (-5.28%)
HOWL : 6.21 (-2.82%)
How Much Upside is Left in Portage Biotech Inc. (PRTG)? Wall Street Analysts Think 160%

The consensus price target hints at a 159.8% upside potential for Portage Biotech Inc. (PRTG). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings...

PRTG : 0.2370 (-5.28%)
New Strong Buy Stocks for November 1st

FFNW, PTEN, PRTG, NTNX and GAMB have been added to the Zacks Rank #1 (Strong Buy) List on November 1, 2022.

PTEN : 11.26 (-2.34%)
NTNX : 60.89 (unch)
FFNW : 20.50 (unch)
PRTG : 0.2370 (-5.28%)
GAMB : 8.74 (-1.24%)
Bears are Losing Control Over Portage Biotech Inc. (PRTG), Here's Why It's a 'Buy' Now

After losing some value lately, a hammer chart pattern has been formed for Portage Biotech Inc. (PRTG), indicating that the stock has found support. This, combined with an upward trend in earnings estimate...

PRTG : 0.2370 (-5.28%)
How Much Upside is Left in Portage Biotech Inc. (PRTG)? Wall Street Analysts Think 268%

The consensus price target hints at a 268.4% upside potential for Portage Biotech Inc. (PRTG). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings...

PRTG : 0.2370 (-5.28%)
Does Portage Biotech Inc. (PRTG) Have the Potential to Rally 206% as Wall Street Analysts Expect?

The mean of analysts' price targets for Portage Biotech Inc. (PRTG) points to a 206.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among...

PRTG : 0.2370 (-5.28%)
UPDATE -- Portage Biotech Announces Results for Fiscal Year Ended March 31, 2022

--Company Continues to Execute on Core Business Model While Enhancing Value Proposition and Pipeline with Recent Transactions-- --Robust Pipeline Now...

PRTG : 0.2370 (-5.28%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Portage Biotech Inc. is a clinical stage immuno-oncology company focused on overcoming immune resistance. The company source, nurture and develop therapies for a variety of cancers. Its drug development pipeline portfolio encompasses products or technologies with established scientific rationales, including...

See More

Key Turning Points

3rd Resistance Point 0.2858
2nd Resistance Point 0.2729
1st Resistance Point 0.2549
Last Price 0.2370
1st Support Level 0.2240
2nd Support Level 0.2111
3rd Support Level 0.1931

See More

52-Week High 4.4000
Fibonacci 61.8% 2.7956
Fibonacci 50% 2.3000
Fibonacci 38.2% 1.8043
Last Price 0.2370
52-Week Low 0.1999

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar